These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24949866)

  • 1. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
    Matosin N; Fernandez-Enright F; Frank E; Deng C; Wong J; Huang XF; Newell KA
    J Psychiatry Neurosci; 2014 Nov; 39(6):407-16. PubMed ID: 24949866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.
    McOmish CE; Pavey G; Gibbons A; Hopper S; Udawela M; Scarr E; Dean B
    J Affect Disord; 2016 Jan; 190():241-248. PubMed ID: 26521087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
    Zavitsanou K; Katsifis A; Mattner F; Huang XF
    Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased metabotropic glutamate 2/3 receptor binding in the perigenual anterior cingulate cortex of Cloninger type 2 alcoholics: a whole-hemisphere autoradiography study.
    Laukkanen V; Kärkkäinen O; Kupila J; Kautiainen H; Tiihonen J; Storvik M
    Alcohol Alcohol; 2015 Jan; 50(1):62-7. PubMed ID: 25425009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and levels of 5-HT
    Veldman ER; Svedberg MM; Svenningsson P; Lundberg J
    Eur Neuropsychopharmacol; 2017 May; 27(5):504-514. PubMed ID: 28318898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in levels of cortical metabotropic glutamate 2 receptors with gender and suicide but not psychiatric diagnoses.
    Dean B; Duncan C; Gibbons A
    J Affect Disord; 2019 Feb; 244():80-84. PubMed ID: 30326345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway.
    Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
    Transl Psychiatry; 2013 Jun; 3(6):e271. PubMed ID: 23778581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression.
    Koethe D; Llenos IC; Dulay JR; Hoyer C; Torrey EF; Leweke FM; Weis S
    J Neural Transm (Vienna); 2007; 114(8):1055-63. PubMed ID: 17370106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age.
    Frank E; Newell KA; Huang XF
    Schizophr Res; 2011 May; 128(1-3):56-60. PubMed ID: 21334855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.
    Lum JS; Millard SJ; Huang XF; Ooi L; Newell KA
    J Psychiatry Neurosci; 2018 Mar; 43(2):102-110. PubMed ID: 29481317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics.
    Newell KA; Matosin N
    BMC Psychiatry; 2014 Jan; 14():23. PubMed ID: 24472577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.
    Matosin N; Frank E; Deng C; Huang XF; Newell KA
    Schizophr Res; 2013 May; 146(1-3):170-6. PubMed ID: 23462049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
    Gupta DS; McCullumsmith RE; Beneyto M; Haroutunian V; Davis KL; Meador-Woodruff JH
    Synapse; 2005 Sep; 57(3):123-31. PubMed ID: 15945063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
    Webster MJ; O'Grady J; Kleinman JE; Weickert CS
    Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
    Zavitsanou K; Katsifis A; Yu Y; Huang XF
    Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.
    Ray MT; Shannon Weickert C; Webster MJ
    Transl Psychiatry; 2014 May; 4(5):e389. PubMed ID: 24802307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus.
    Blümcke I; Behle K; Malitschek B; Kuhn R; Knöpfel T; Wolf HK; Wiestler OD
    Brain Res; 1996 Oct; 736(1-2):217-26. PubMed ID: 8930327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    JAMA Psychiatry; 2022 Nov; 79(11):1102-1109. PubMed ID: 36129716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.